Heathy Casa

Stay updated with news, ideals and new technology for your health!

NLM Technical Bulletin, May-Jun 2018, Policy Change for Multiple Translations of the Same Journal Article

Table of Contents: 2018 MAY–JUNE No. 422
Previous Next
Policy Change for Multiple Translations of the Same Journal Article. NLM Tech Bull. 2018 May-Jun;(422):b4.
2018 May 21 [posted]
As of June 2018, only the English version of multi-language articles will appear in PubMed/MEDLINE and be indexed for MEDLINE. In the past, when journals published multiple translations of an article in the same issue, the English version was indexed for MEDLINE & citations for any non-English versions were included in PubMed as PubMed-not-MEDLINE (where Medical Subject Headings are not added). In many cases, users will still have access to the non-English versions of these articles when they access the full text on the publisher’s Web site.

5 Tips for a Healthy Vacation

To help protect your skin & eyes while outside, wear sunglasses, a hat, & broad spectrum sunscreen with an SPF of 15 or higher.

 Subscribe: FDA Consumer Health Information
Español
Planning your next beach vacation? While having fun in the sun, consider these five tips to make sure your trip is a healthy one.
Avoid Tanning, Be Sun Safe
Thinking about getting a “healthy tan” over vacation? Think again. When you’re exposed to sunlight, an increase in your skin pigment (called “melanin”) can be a sign of damage. Ultraviolet radiation from the sun can cause wrinkles & dark spots among other problems—and tanning puts you at higher risk for skin cancer. Plus, sunlight reflecting off of sand or water increases exposure to UV radiation & increases your risk of developing eye problems.
But sunny days can still figure into your trip. Here’s how to be sun safe.
Use sunscreen. Wear a broad spectrum sunscreen that protects against UVA and UVB rays, and choose an SPF of 15 or higher. You need at least one ounce of sunscreen lotion (the size of a golf ball) to cover your body. Reapply at least every 2 hours, or every 40 to 80 minutes when swimming or sweating, according to the directions on the product label. And limit the time your skin is exposed to the sun between 10 a.m. & 2 p.m.
Wear sunglasses. Certain sunglasses can help protect your eyes. Choose sunglasses labeled with a UVA/UVB rating of 100% to get the most UV protection.
Wear protective clothing. Consider wearing…

Century Snacks LLC Issues Allergy Alert On Undeclared Milk, Soy, Wheat & Cashews in Snak Club Family Size Tropical Trail Mix

Century Snacks of Commerce, CA, is recalling certain 16 OZ. bags of Tropical Trail Mix because they may contain milk, soy, wheat & cashew allergens & this is not declared on the package. Individuals who have an allergy or severe sensitivity to milk, soy, wheat or cashews run the risk of serious or life-threatening allergic reaction if they consume these products.
Tropical Trail Mix was distributed to retail outlets throughout Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New York, Ohio, Pennsylvania, South Carolina, Texas, Virginia & Washington.
The affected packages of 16 OZ. Tropical Trail Mix have UPC number, 0-87076-64462-8, with lot code “BEST BY DEC 27 2018 TP3B T” printed on the front of the package. The Tropical Trail Mix bags may contain Yogurt Trail Mix inside the bags.
This is an example of a package of Tropical Trail Mix & the location of the lot code.
Century Snacks believes this is an isolated incident, due to an error by our packaging supplier, involving a very small quantity of incorrectly filled Tropical Trail Mix bags. No illnesses or adverse reactions have been reported to date.
Distributors have been notified & have been given a form to return the product for credit. Consumers should return the product to the store for a refund or exchange. Please contact our Director of Food Safety & Quality, Tony Palacios at 323-278-9578 x427, (Monday-Friday 8:00 am to 5:00 pm) should you have any questions. ### …

Male Depression May Lower Pregnancy Chances Among Infertile Couples, NIH Study Suggests

News Release
Thursday, May 17, 2018 Study also links women’s use of non-SSRI antidepressants to early pregnancy loss. Among couples being treated for infertility, depression in the male partner was linked to lower pregnancy chances, while depression in the female partner was not found to influence the rate of live birth, according to a study funded by the National Institutes of Health.
The study, which appears in Fertility & Sterility, also linked a class of antidepressants known as non-selective serotonin reuptake inhibitors (non-SSRIs) to a higher risk of early pregnancy loss among females being treated for infertility. SSRIs, another class of antidepressants, were not linked to pregnancy loss. Neither depression in the female partner nor use of any other class of antidepressant were linked to lower pregnancy rates.
“Our study provides infertility patients and their physicians with new information to consider when making treatment decisions,” said study author Esther Eisenberg, M.D., of the Fertility & Infertility Branch at NIH’s Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), which funded the study.
Citing previous studies, the authors noted that 41 percent of women seeking fertility treatments have symptoms of depression. In addition, a study of men seeking IVF treatments found that nearly 50 percent experienced depression. The authors conducted the current study to evaluate the potential influence of depression in couples seeking non-IVF treatments.
The researchers combined data from two previous studies funded by NICHD’s Reproductive Medicine Network. One study compared the effectiveness of two ovulation-inducing drugs for establishment of pregnancy &…

International Study Suggests Combination Therapy May Prevent Stroke in Certain People

News Release
Thursday, May 17, 2018 NIH-funded trial finds lower rate of secondary stroke but small risk of bleeding. Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel & aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.  The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal & did not occur in the brain. The results were presented at the 4th European Stroke Organization Conference in Gothenburg, Sweden. The study was supported by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS).
“These findings are likely to have a global effect on clinical practice, as these drugs are easily available in many hospitals and clinics,” said Walter Koroshetz, M.D., director of NINDS. “As the benefit of the combination was concentrated in the first two weeks while risk of bleeding was constant over 90 days, it may be especially valuable in acute management of a minor ischemic stroke or transient ischemic attack (TIA).”
The Platelet-Oriented Inhibition in New TIA & minor ischemic stroke (POINT) clinical trial follows an earlier study, which showed benefits of this drug combination in a Chinese population. POINT was conducted to see whether the benefits could be expanded to a more diverse group of patients.
The study, led by S. Claiborne Johnston, M.D., Ph.D., dean & professor of neurology at…

Potassium

Table of Contents

What is potassium & what does it do?
Potassium is a mineral found in many foods. Your body needs potassium for almost everything it does, including proper kidney & heart function, muscle contraction, & nerve transmission.
How much potassium do I am need?
The amount of potassium you need each day depends on your age. Average daily recommended amounts are listed below in milligrams (mg).
Life Stage
Recommended Amount
Birth to 6 months
400 mg
Infants 7–12 months
700 mg
Children 1–3 years
3,000 mg
Children 4–8 years
3,800 mg
Children 9–13 years
4,500 mg
Teens 14–18 years
4,700 mg
Adults 19+ years
4,700 mg
Pregnant teens & women
4,700 mg
Breastfeeding teens & women
5,100 mg

 
What foods provide potassium?
Potassium is found in many foods. With thoughtful planning, you can get recommended amounts of potassium by eating a variety of foods, including the following:
Fruits, such as dried apricots, prunes, raisins, orange juice, & bananas
Vegetables, such as acorn squash, potatoes, spinach, tomatoes, & broccoli
Lentils, kidney beans, soybeans, and nuts
Milk & yogurt
Meats, poultry, & fish
Salt substitutesPotassium is an ingredient in many salt substitutes that people use to replace table salt. If you have kidney disease or if you take certain medications, these products could make your potassium levels too high. Talk to your healthcare provider before using salt substitutes.
What kinds of potassium dietary supplements are available?
Potassium is found in many multivitamin/multimineral supplements and in supplements that contain only potassium. Potassium in supplements comes in many different forms— a common form is potassium chloride, but other forms used in supplements are potassium citrate, potassium phosphate, potassium aspartate, potassium bicarbonate, & potassium gluconate. Research has…

FDA Approves First Medication to Reduce Opioid Withdrawal Symptoms

Courtesy of US WorldMeds, LLC.
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S. Food & Drug Administration. Lofexidine, an oral tablet, is designed to manage the symptoms patients often experience during opioid discontinuation. Opioid withdrawal symptoms, which can begin as early as a few hours after the drug was last taken, may include aches & pains, muscle spasms/twitching, stomach cramps, muscular tension, heart pounding, insomnia/problems sleeping, feelings of coldness, runny eyes, yawning, & feeling sick, among others. The product will be marketed under the brand name LUCEMYRATM.
In 2016, more than 42,000 people died from an opioid overdose, or approximately 115 people per day. Although effective treatments exist for opioid addiction, painful & difficult withdrawal is one of the reasons treatment fails, & relapse occurs. By alleviating symptoms associated with opioid withdrawal, LUCEMYRA could help patients complete their discontinuation of opioids & facilitate successful treatment. To date, no other medications have been approved to treat opioid withdrawal symptoms.
LUCEMYRA will be marketed by US WorldMeds, a specialty pharmaceutical company that acquired a license for lofexidine from Britannia Pharmaceuticals in 2003. NIDA provided funding to US WorldMeds to support clinical trials to document the clinical pharmacokinetics of lofexidine and to test medical safety & efficacy of the medication, as compared to a placebo, among patients undergoing medically supervised opioid discontinuation. LUCEMYRA is expected to be…

NLM Technical Bulletin, May-Jun 2018, NLM to Discontinue PubMed Health on October 31, 2018

Coleman J. NLM to Discontinue PubMed Health on October 31, 2018. NLM Tech Bull. 2018 May-Jun;(422):e3.
The National Library of Medicine (NLM) has decided to discontinue PubMed Health effective October 31, 2018, as the majority of information it provides is available in more heavily used NLM resources, such as PubMed, Bookshelf, & MedlinePlus. By focusing our attention on these highly used platforms, we will be able to better serve users & meet their needs for access to quality health & medical information.
PubMed Health was introduced eight years ago as a portal for systematic reviews as well as consumer health information. Systematic reviews have been, & will remain, findable through PubMed, & the full text (when available) will continue to be accessible through Bookshelf.  One simple way to limit PubMed search results to systematic reviews is to mark the check box for them in “Customize” under “Article types,” located in the top left corner of the search results page (see Figure 1). Figure 1: Article types on the search results page.
Within the next year, PubMed will be adding “Systematic Review” as a Publication Type [pt], which will allow users to find systematic reviews by including the phrase in their search query (e.g., breast cancer & systematic review[pt]).
Also within the next year, PubMed will include a default check box for systematic reviews. You can get a sense of how that will look by visiting PubMed Labs, our Web site for experimenting with potential new features & interfaces for PubMed.
Most of the consumer health…

Mas Food Services Co. Issues Allergy Alert on Undeclared Sulfites in The Peruchef Dry Potato

Mas Food Services Co. of Oakland Park, FL is recalling its 15 ounce packages of The Peruchef brand dry potato because it may contain undeclared sulfites. People who have an allergy or severe sensitivity to sulfites run the risk of serious or life-threatening allergic reaction if they consume these products.
1200 units of the above-mentioned product were distributed to & available for purchase at retail supermarkets in Florida, Virginia, New Jersey, & Maryland.
The Peruchef Brand Dry Potatoes come in a 15-ounce, printed plastic bag marked with “Dry potato” and “Papa Seca Serrana” on the label with an expiration date of August 2019. The product UPC is 7755864000194.
No illnesses or allergic reactions involving this product have been reported to date.
The voluntary recall was initiated after routine sampling by the Florida State Dept. of Agriculture & analysis by food laboratory personnel revealed the presence of sulfites in the product, which were not declared on the label.
Consumers who have purchased The Peruchef Brand Dry Potato are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at (954) 735-7442, Monday-Friday, 8:00AM-1:30PM EST.
### …

Ill-Conceived, Well-Drawn Graphic Medicine Program Draws Fans

In an era when digital info rules & high tech is titan, an emerging approach in health communication is leading us literally back to the drawing board. “Graphic medicine”—a field using comics to convey messages about wellness & illness—has burgeoned over the last decade and a new installation at the National Library of Medicine is giving it a close-up.
Artist & author Ellen Forney served as guest curator of the NLM graphic medicine exhibition. (Photo by Chia-Chi Charlie Chang)

“In this day & age when we are so focused at NIH on data-driven discovery, to realize a whole new genre as data is out there waiting for us is extremely exciting,” said NLM director Dr. Patricia Flatley Brennan, opening a special public program recently in conjunction with the exhibition “Graphic Medicine: Ill-Conceived & Well-Drawn.”
The term graphic medicine isn’t exactly new. Welsh physician-artist-writer Ian Williams coined the phrase in 2007 to describe the comics—images sequentially paired with words to tell a story—that he & other people were creating to depict their experiences in health care. A website he developed using the term caught the attention of like-minded artists, writers, care providers, and educators whose professional & personal lives had also led them to communicate medical topics through comics. They held the first conference on comics & medicine in 2010. That launched the graphic medicine movement.
NLM invited several of the field’s pioneers to an event in Lister Hill Auditorium to talk about the new discipline, its origins & impact, & future directions.
“Comics & graphic novels…

Heathy Casa © 2018 Frontier Theme
Do NOT follow this link or you will be banned from the site!